QURE News Alert Uniqure B.V. (QURE) 14.75 12/25/2014 15:34:5

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Uniqure B.V. (QURE) 14.75 $QURE

uniQure N.V. (QURE) Jumps: Stock Adds 6.3% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Dec 08, 7:51AM CST
uniQure N.V. (QURE) was a big mover last session, as its shares rose over 6% on the day.
QURE: 14.75 (+0.22), ANIP: 55.24 (+1.79), ILMN: 186.22 (+2.72), AFFX: 9.80 (+0.05)

uniQure to Present at the Oppenheimer 25th Healthcare Conference - NYC
GlobeNewswire - Fri Dec 05, 4:09AM CST
uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present at the Oppenheimer 25th Healthcare Conference - NYC, to be held December 10-11, 2014, at The Crowne Plaza Hotel in New York City, NY, USA.
QURE: 14.75 (+0.22)

uniQure reports Q3 results
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 7:37AM CST

QURE: 14.75 (+0.22)

uniQure EPS of -€0.51
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 6:52AM CST

QURE: 14.75 (+0.22)

uniQure Announces Results for the Third Quarter of 2014
GlobeNewswire - Mon Dec 01, 6:33AM CST
uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced results for the third quarter of 2014.
QURE: 14.75 (+0.22)

uniQure N.V. (QURE) in Focus: Stock Soars 17.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Nov 28, 8:21AM CST
uniQure N.V. (QURE) was a big mover last session, as the company saw its shares rise by nearly 19% on the day.
QURE: 14.75 (+0.22), ANIP: 55.24 (+1.79), AMAG: 43.02 (+0.90), AFFX: 9.80 (+0.05)

UniQure sets price record with Glybera
Seeking Alpha - at Seeking Alpha - Wed Nov 26, 2:33PM CST

BIS: 47.26 (-1.74), QURE: 14.75 (+0.22), BIB: 122.51 (+3.83), ALXN: 181.96 (+3.09), IBB: 299.80 (+5.12)

Uniqure (QURE) Shares March Higher, Can It Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Nov 26, 7:32AM CST
Uniqure (QURE) Shares March Higher, Can It Continue?
QURE: 14.75 (+0.22)

uniQure to Host Investor Day in New York City
GlobeNewswire - Fri Nov 21, 8:34AM CST
uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that it will be hosting an Investor Day and simultaneous webcast in New York City on December 1, 2014, starting at 8:30 a.m. uniQure management will be joined by distinguished guests to discuss the Company's strategy, clinical programs and uniQure's vision of how gene therapy will change the future of medicine.
QURE: 14.75 (+0.22)

uniQure to Present at Jefferies Global Healthcare Conference - London
GlobeNewswire - Mon Nov 10, 4:03AM CST
uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that Jorn Aldag, CEO, will present a corporate overview at Jefferies Global Healthcare Conference - London, to be held November 19-20, 2014.
QURE: 14.75 (+0.22)

AIPGENE Consortium Presents 1 Year Follow-Up Clinical Data from Acute Intermittent Porphyria Phase I Clinical Trial Using AAV5-PBGD Gene Therapy Candidate
GlobeNewswire - Mon Oct 27, 5:45AM CDT
--Top-line Results Confirming Safety, Liver Transfection Presented at ESGCT Conference--
QURE: 14.75 (+0.22)

uniQure to Present at the Leerink Partners Rare Disease Roundtable Conference
GlobeNewswire - Thu Sep 25, 8:08AM CDT
uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced that its management will present at the Leerink Partners Rare Disease Roundtable Conference, October 1st, 2014, to be held at the Le Parker Meridien Hotel, New York City, NY, USA.
QURE: 14.75 (+0.22)

uniQure Announces Results for the Second Quarter and First Half of 2014 and Provides Update on Gene Therapy Programs
GlobeNewswire - Tue Sep 02, 5:15AM CDT
uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced results for the second quarter of 2014 and an update on multiple gene therapy programs.
QURE: 14.75 (+0.22)

Can the Rally in Uniqure (QURE) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Aug 20, 8:29AM CDT
Can the Rally in Uniqure (QURE) Shares Continue?
QURE: 14.75 (+0.22)

uniQure Acquires Cardiology Gene Therapy Company InoCard
GlobeNewswire - Mon Aug 11, 3:35PM CDT
uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced the acquisition of InoCard GmbH, an innovative, early-stage biotechnology company focused on the development of gene therapy approaches for cardiac disease. InoCard has developed a novel gene therapy to preclinical proof of concept, for the one-time treatment of congestive heart failure (CHF), a rapidly progressing disease affecting 26 million people worldwide. InoCard founders Prof. Patrick Most and Prof. Hugo Katus will join uniQure as Managing Director of uniQure in Germany and Chairman of the Scientific Advisory Board, for Cardiovascular Diseases, respectively.
QURE: 14.75 (+0.22)

Chiesi and uniQure Provide Update on Glybera(r) Launch
GlobeNewswire - Mon Aug 04, 6:11AM CDT
uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, and Chiesi Farmaceutici S.p.A. ("Chiesi" , a leading international pharmaceutical company, today provided an update on preparations relating to the launch of Glybera (alipogen tiparvovec), the first gene therapy product approved in the European Union, for the treatment of the orphan disease lipoprotein lipase deficiency (LPLD). Chiesi has exclusive rights to commercialize Glybera in the EU and selected additional territories. Expanding on the original launch strategy, Chiesi and uniQure decided to include in the pricing and reimbursement applications for launch, the six-year follow-up pancreatitis data from the study AMT 011-05, announced June 3, 2014. As a consequence, Chiesi now expects to launch Glybera in the fourth quarter of 2014/first quarter of 2015.
QURE: 14.75 (+0.22)

Nasdaq stocks posting largest percentage decreases
AP - Thu Jul 17, 12:19PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:
NVEE: 12.78 (-0.19), PBHC: 9.81 (+0.01), BB.TO: 12.41 (-0.17), IRMD: 12.64 (+0.14), QURE: 14.75 (+0.22), BBRY: 10.67 (-0.13), SAL: 26.77 (+0.27), BRID: 7.01 (-0.45), POZN: 7.86 (+0.07), SNDK: 100.65 (+0.27)

uniQure Secures Additional $10M Venture Loan from Hercules Capital
GlobeNewswire - Tue Jul 01, 4:16AM CDT
uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced the closing of an additional $10 million venture debt loan with Hercules Technology Growth Capital, Inc. (HTGC), increasing the total loan amount to $20 million including the initial $10 million that uniQure announced in July 2013.
HTGC: 15.13 (+0.39), QURE: 14.75 (+0.22)

uniQure and Medison Sign Glybera Distribution Agreement for Israel
PR Newswire Europe - Wed Jun 18, 8:27AM CDT
AMSTERDAM and PETACH TIKVA, Israel, June 18, 2014 /PRNewswire/ --
QURE: 14.75 (+0.22)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

SanMar’s Lott Tops Promo Products Power 50 Again in 2026

Updated Category News Views 257

Branded hoodies and logo tumblers rarely make Wall Street’s pulse race, but the numbers behind them deserve a hard look. Jeremy Lott, president and CEO of SanMar, was named the most influential leader in the U.S. promotional-products business for the second consecutive year, taking No. 1 in the 2026 Counselor Power 50 ranking. Awards can be fluff. A repeat win beside...

Continue Reading
Kids First Data Sharing Raises Pediatric Research Bar

Updated Category News Views 15

Thirty-eight thousand children’s records are not a headline gimmick; they are a serious argument for treating research data as an asset that must keep working after the first study ends. The Gabriella Miller Kids First Data Resource Center’s ten-year review, published in the September 2026 issue of The American Journal of Human Genetics, makes that argument with...

Continue Reading
TIER IV Simplifies Autonomous Driving with CARLA 1.0

Updated Category News Views 138

No More Detours in Autonomous Development Ever messed with a puzzle that just won't fit until suddenly, it clicks? That's what TIER IV just pulled off with their latest work on CARLA 1.0, the open-source simulator. There's no more mucking about with that separate Python-based bridge to get things communicating—now we're talking native Autoware support. A direct line to...

Continue Reading
Autoliv's Omni Safety Award Is a Promising Early Signal

Updated Category News Views 68

Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...

Continue Reading
Yatsen’s November 25 Report Is the Real Beauty Test

Updated Category News Views 46

Beauty shelves can hide a lot of sins, but earnings day tends to drag them into fluorescent light. Yatsen will release unaudited third-quarter 2026 financial results before the U.S. market opens on Wednesday, November 25, then management will take questions at 7:30 a.m. Eastern Time. For anyone following NYSE:YSG, this is not a results story yet. It is a calendar marker,...

Continue Reading
Avelo Tests Loyalty Math With WeSalute Fare Discounts

Updated Category News Views 297

Airline discounts can look like generosity until the load factor starts talking back. Avelo Airlines has joined WeSalute with fare discounts for active-duty military members, veterans, first responders, nurses, medical professionals, public servants, teachers and eligible family members. It is a sensible move for a young carrier built around smaller airports and lower...

Continue Reading
Somerville’s New Immersive Bet Has Room to Grow Locally

Updated Category News Views 0

A passcard, a hidden door, and 12,000 square feet of mischief have landed at Somernova. Edge of Elsewhere, the new flagship attraction from Boston-area creative studio Midnight Mansion, is open in Somerville’s Union Square as of November 18, 2026. It is part interactive art installation, part puzzle game, part physical story world. That sounds delightfully odd, which is...

Continue Reading
Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 130

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
Ideas Abu Dhabi Puts Water Innovation on Stage

Updated Category News Views 25

Water rarely gets the spotlight until a pipe fails, a harvest shrinks, or a city starts rationing. That is why the agenda around Ideas Abu Dhabi at the 2026 UN Water Conference deserves more than the usual polite nod given to conference programming. From 7 to 10 December in Abu Dhabi, this is shaping up as a public-facing attempt to connect a hard physical problem with...

Continue Reading
TORM Rejects Hafnia's No-Premium Merger Pitch Again

Updated Category News Views 26

A 19.8% shareholder heading for the exit can rattle a shipping stock before breakfast, and TORM has answered the noise with a flat refusal to pretend Hafnia's merger approach was good enough. The message from Hellerup on November 18 is unusually blunt: Hafnia made several conditional, all-share proposals, TORM saw no effective premium for control, and the board rejected...

Continue Reading

Top 5 Most Recently Viewed Articles

Enhanced Insurance Solutions for Virginians Amid Rising Costs

Updated Category News Views 130

Understanding the Rising Costs of Bodily Injury Claims Bodily injury costs in Virginia are on the rise, impacting the financial health of many residents. Unforeseen incidents, from car accidents to dog bites, can swiftly escalate into significant financial burdens. Reports indicate that liability claims have surged, with the average payout increasing significantly since...

Continue Reading
Investors Notify: Class Action Suit Against Lockheed Martin

Updated Category News Views 245

Overview of the Class Action Lawsuit Bragar Eagel & Squire, P.C. has recently announced the initiation of a class action lawsuit against Lockheed Martin Corporation (NASDAQ: LMT). This lawsuit is intended for all individuals and entities that acquired Lockheed Martin securities during the designated class period, which spans from January 23, 2024, to July 21, 2025. The...

Continue Reading
Market Trends Lead MUJ Stock to New Yearly Low of $10.97

Updated Category News Views 186

Understanding the Decline of MUJ Stock In a challenging economic landscape, BlackRock's MuniHoldings New Jersey Quality Fund (MUJ) stock has faced significant declines, recently hitting a 52-week low of $10.97. This shift in value reflects broader market trends affecting municipal bond funds and investor sentiment towards interest rates and credit risk. Key Indicators Of...

Continue Reading
Public Service Company of New Mexico Announces Q1 Dividend

Updated Category News Views 92

Public Service Company of New Mexico Announces Quarterly Dividend The Board of Directors at Public Service Company of New Mexico, part of TXNM Energy (NYSE: TXNM), has officially declared its regular quarterly dividend. This announcement marks a continued commitment to returning value to shareholders. The declared dividend stands at $1.145 per share, attributed to the...

Continue Reading
Nations Photo Lab Earns Recognition for Premium Photo Services

Updated Category News Views 437

Nations Photo Lab Recognized for Outstanding Photo Services In an exciting development within the photo printing sector, Nations Photo Lab has been acknowledged as a leading provider of premium photo printing and framing services. This recognition highlights the increasing demand for unique and high-quality wall art in both residential and commercial spaces. The rise of...

Continue Reading